This table presents results for the time period October thru December 2009 (Ryan White Part B Third Quarter) showing the HRSA/HAB Tier 1 Clinical Performance Measures. Because services and client population vary widely in our provider angencies these also show great diversity. Please note additional comments below the chart.

Service Outcome Measures	CA	DPCHC	PU	SAAF	CTSS	WMCPHD
Medical Visits: Percentage of (served) clients with HIV infection who had 2 or more medical visits in an HIV care setting in the measurement year.	82.5%	83%	76.6%	46.9%	54.5%	93.2%
CD4 T-cell count: Percentage of (served) clients with HIV infection who had 2 or more CD4 T-cell counts performed in the measurement year.	88.2%	81.8%	65.6%	77.6%	40.6%	93.2%
HAART: Percentage of (served) clients with AIDS who were prescribed HAART.	95.8%	97.4%	15%	93.1%	95.6%	100%
PCP Prophylaxis: Percentage of (served) clients with HIV infection and a CD4 T-cell count below 200 cells/mm who were prescribed PCP prophylaxis.	93.8%	91.7%	31.6%	87.5%	80%	100.0%
ARV Therapy For Pregnant Women: Percentage of (served) pregnant women with HIV infection who are prescribed antiretroviral therapy.	100%	60% [100%]	50%	N/A	N/A	N/A

Our service providers have been tracking statistics on these five quality measurements for more than a year. The agencies now have a good understanding of what data is required to capture these statistics, but some of the reporting parameters include clients no longer served by the agency and exclude those who have recently entered into care with the agency. The ARV Therapy For Pregnan Women measure has proved to be challenging both because of numerous restrictions on who is counted and the extremely low client count (this quarter a total of 13 women are tracked in the six provider organizations). Results in brackets reflect the provider's assessment of the reported measure. In spite of these challenges, all of our contractors continue to improve their performance in these areas.

Posted by BVCOG-HIV at 03:06 PM | Permalink